课题基金 / 基金详情

The development of controlled release-drug utilizing new quinolones for perlodontitis

The development of controlled release-drug utilizing new quinolones for perlodontitis
新型喹诺酮类治疗牙周炎控释药物的研制
批准号:
09557153
负责人:
OKADA Hiroshi
金额:
$7.68万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

OKADA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在利用局部给药系统开发治疗牙周病的新型化疗药物。托氟沙星(TFLX)对牙周病细菌具有良好的抗菌活性,因此被选为该新药的抗菌剂。在我们的初步研究中,我们考察了各种骨架的控释活性。其中,以硫酸铝钾和HPMC2208为基料的非水凝胶性能最好。根据这一结果,将4%的TFLX与以硫酸铝钾和HPMC2208为基质的凝胶混合制成试剂盒。同时考察了TFLX在牙周袋中的持续释放情况。结果表明,受试试剂在牙周袋内应用后48h仍能保持10/γg/ml的TFX浓度。该试剂应用于牙周袋的安全性也得到了证实,因为该试剂应用于牙周袋时,在医疗和牙科条件下均未出现副作用。然后,我们评估了该试剂局部应用于牙周袋预处理的临床效果。应用控释药物2周后,与非治疗或单纯使用基质相比,受试部位的临床参数没有明显改善。然而,本研究建立的牙龈卟啉单胞菌(Pg)的高灵敏度检测方法显示,在使用该试剂后2周,使用该试剂的部位与其他部位相比,PG所占比例有下降的趋势。这些数据表明,本研究开发的新试剂有可能成为具有局部给药系统特点的独特的牙周炎化疗药物之一。
英文摘要
This study was conducted to develop the new chemotherapeutic agents for periodontal diseases utilizing the local drug delivery system. Tosfloxacin (TFLX) was selected as anti-bacterial agent for this new agent because of its superior anti-bacterial activity against periodontopathic bacteria. We examined the controlled release activity of various matrices in our preliminary studies. Among them, non-hydrated gel based on potassium aluminum sulfate and HPMC2208 showed the best characteristics for its purpose. According to this result, test reagent was prepared by mixing 4% TFLX with gel based on potassium aluminum sulfate and HPMC2208. The persistence of TFLX releasing in the periodontal pockets using test reagent was also examined. In result, test reagent retained TFLX at the concentration of 10/γg/ml even 48 hours after application in the periodontal pocket. The safety of this reagent in application to periodontal pockets was also confirmed, because the side effects in medical and dental condition did not appear when this reagent was applied to periodontal pockets. Then, we evaluated the clinical effects of topical application of this reagent for pretreated periodontal pockets. The clinical parameters of the tested sites 2 weeks after the application, where the controlled release-drug was applied, was not significantly improved in comparison with the sites where non-treatment or matrix alone was applied. However, the high sensitive detectable method of Porphyromonas gingivalis (Pg) developed in this study showed that a tendency to decrease the proportion of Pg in the sites applied the test reagent in comparison with the other sites at 2 weeks after the application. These data show that the new reagent developed in this study has the possibility of becoming one of the unique chemotherapeutic agents for periodontitis with the feature of local drug delivery system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of process technology for nitride semiconductor based integrated circuits for harsh environment electronics
  • 批准号:
    20K04579
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.75万
  • 财政年份:
    2020
  • 负责人:
    OKADA Hiroshi
  • 依托单位:
Effects of Electorates' Candidate Orientations on Voting Behavior in Different Kinds of Elections
  • 批准号:
    16K03464
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.66万
  • 财政年份:
    2016
  • 负责人:
    OKADA Hiroshi
  • 依托单位:
Rare-earth doped gallium nitride semiconductor light emitting device and their application
  • 批准号:
    22560328
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2010
  • 负责人:
    OKADA Hiroshi
  • 依托单位:
Three-dimensional fracture mechanics software platform enabling collaborative software development for building safe society
  • 批准号:
    22560149
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.66万
  • 财政年份:
    2010
  • 负责人:
    OKADA Hiroshi
  • 依托单位:
海外基金